Real Estate Committee

The Real Estate Committee Chairs are Gail Maderis, CEO FivePrime Therapeutics and Catherine Sharpe, Fibrogen.

FivePrime Therapeutics, Inc. is a biotherapeutics drug discovery company developing best in class therapeutic proteins and antibodies for treatment of clinical indications in oncology, immunology, diabetes, and regenerative medicine. Founded in 2002 by Lewis T. Williams, MD PhD, FivePrime is privately held and backed by premier investors including Kleiner Perkins Caufield & Byers, Texas Pacific Group, Versant Ventures and Advanced Technology Ventures. Visit their website at www.fiveprime.com.

Five Prime was the first biotech company to move into the Mission Bay complex.

Read the Press Release.

FibroGen, a privately-owned biotechnology company currently based in South San Francisco, plans to move its headquarters and research and development operations to the Mission Bay site in the fourth quarter of 2008. FibroGen will be the largest biotechnology company to move into Mission Bay since the City began to actively develop its biotech cluster in 2005. In late 2005, the city passed the Biotech Payroll Tax Exemption, a move championed by Mayor Gavin Newsom and Supervisor Michela Alioto-Pier, which provided a key incentive to FibroGen to move to Mission Bay.

Read the Press Release. www.fibrogen.com

If you are interested in joining the Real Estate committee or attending our events please complete the form below and we'll be in touch:

* Indicates a required field.

 

*Name
*Title
*Company
*Phone
*E-mail
Interests (please check at least one)
Finance
Strategic Planning
Communications
Education
Real Estate
Additional Comments